GL
Globe LifeNYSEFinancialsInsurance - LifeSnapshot 2026-05-08
As of May 8, 2026, GL has a composite score of 21.2, categorized as "mild favorable." This score is influenced by a medium confidence level of 75.0 and reflects strengths in management (71.0) and quality (80.2), while facing challenges from macroeconomic factors, particularly a macro score of -7.7. The analysis is provisional, indicating that the data may be subject to change.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.05
- Bonus0.00
Why this rank
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $3.71 → $3.69 (-0.6% / 30d). 2 raised, 3 cut, 8 covering analysts.
0 upgrades, 0 downgrades / 30d, 2 maintained. 73% of analysts rate Buy.
1 PT revisions / 30d. Avg target 20.5% above current price.
0 positive, 0 negative / 30d.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
1 material event in the last 24 months — top 1 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Increase EPS guidance for 2026growthbehind0% progress
4/22: “The Company also increased full-year 2026 earnings guidance to a range of $15.40 to $15.90.”
Why this status
Stated in 2 of last 2 quarters. EPS guidance increased from $14.95-$15.65 to $15.40-$15.90 for 2026, reflecting a $0.35 increase at the midpoint. This suggests a positive outlook, with the company delivering on its growth trajectory.
- 2.Repurchase shares of common stockcapital allocationmixed35% progress
4/22: “1.4 million shares of Globe Life Inc. common stock were repurchased during the quarter.”
Why this status
Stated in 2 of last 2 quarters. Globe Life repurchased 1.4 million shares in Q1 2026, following 1.3 million in Q4 2025. This consistent buyback activity indicates a focus on capital allocation, with the company delivering on its repurchase strategy.
- 3.Increase life and health net salesgrowthmixed63% progress
4/22: “Life net sales grew at each division, resulting in a 6% increase in total life net sales over the year-ago quarter.”
Why this status
Stated in 2 of last 2 quarters. Life net sales increased 6% in Q1 2026, following an 11% increase in Q4 2025. Health net sales also showed strong growth. The company is delivering on its growth strategy in life and health segments.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 16%; 252d 20%.
Drawdown — Max 1y −11%. Bad day move −2%.
Beta to sector ETF (XLF) — 0.70 over 1y.
Liquidity — score 96/100.
Sub-scores — vol 66/100, drawdown 78/100, beta 70/100, earnings vol —.
via XLF
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Increase EPS guidance for 2026
GrowthGlobe Life increased its full-year 2026 earnings guidance to a range of $15.40 to $15.90 per share.
BehindStated in 2 of last 2 quarters. EPS guidance increased from $14.95-$15.65 to $15.40-$15.90 for 2026, reflecting a $0.35 increase at the midpoint. This suggests a positive outlook, with the company delivering on its growth trajectory.
0%CEO/CFO:“The Company also increased full-year 2026 earnings guidance to a range of $15.40 to $15.90.”Press releaseSource dated 2026-04-22Stated 2 of last 8 quartersFirst seen 2026-04-22Show history (2)
- 2026-Q1Press release
“The Company also increased full-year 2026 earnings guidance to a range of $15.40 to $15.90.”
- 2025-Q4Press release
“Globe Life projects net operating income between $14.95 to $15.65 per diluted common share for the year ending December 31, 2026.”
- #2
Repurchase shares of common stock
Capital allocationGlobe Life continues its share repurchase program, buying back 1.4 million shares in Q1 2026.
MixedStated in 2 of last 2 quarters. Globe Life repurchased 1.4 million shares in Q1 2026, following 1.3 million in Q4 2025. This consistent buyback activity indicates a focus on capital allocation, with the company delivering on its repurchase strategy.
35%CEO/CFO:“1.4 million shares of Globe Life Inc. common stock were repurchased during the quarter.”Press releaseSource dated 2026-04-22Stated 2 of last 8 quartersFirst seen 2026-04-22Show history (2)
- 2026-Q1Press release
“1.4 million shares of Globe Life Inc. common stock were repurchased during the quarter.”
- 2025-Q4Press release
“1.3 million shares of Globe Life Inc. common stock were repurchased during the quarter.”
- #3
Increase life and health net sales
GrowthGlobe Life aims to grow life and health net sales, with significant increases reported across divisions.
MixedStated in 2 of last 2 quarters. Life net sales increased 6% in Q1 2026, following an 11% increase in Q4 2025. Health net sales also showed strong growth. The company is delivering on its growth strategy in life and health segments.
63%CEO/CFO:“Life net sales grew at each division, resulting in a 6% increase in total life net sales over the year-ago quarter.”Press releaseSource dated 2026-04-22Stated 2 of last 8 quartersFirst seen 2026-04-22Show history (2)
- 2026-Q1Press release
“Life net sales grew at each division, resulting in a 6% increase in total life net sales over the year-ago quarter.”
- 2025-Q4Press release
“Net sales of life insurance increased 11% for the quarter, and net health sales increased 71%.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
P/E over the last 5 years
71 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
GL Globe Life | +21 | fair | low |
BRK-B Berkshire Hathaway | +6.0 | — | moderate |
JPM JPMorgan Chase | -0.9 | full | low |
V Visa Inc. | +20 | — | low |
MA Mastercard | +15 | full | low |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If rates state reverses from -0.37 (negative) to +0.37 (positive)+6.6 pts
- If financials sector trend rises from +0.07 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is cut (currently RAISED as of 2026-04-22)-16 pts
- If financials sector trend falls from +0.07 into 'weakening' (<= -0.20)-5.0 pts
- If growth state reverses from +0.25 (positive) to -0.25 (negative)-3.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-05-044d agoItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Other Officers. (a) Not applicable. (b) Linda L. Addison and Marilyn A. Alexander retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 30, 2026. (c) Not applicable. (d) Not applicable. (e) Not applicable.
executive changeneutralscore 51 - 2026-04-2217d agoItem 2.02
Results of Operations and Financial Condition. On April 22, 2026, Globe Life Inc. issued a press release announcing its first quarter 2026 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Excha…
earnings preannouncementneutralscore 45
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.